Stay updated with breaking news from Phase 2 Trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A phase 2 trial of stenoparib in advanced recurrent ovarian cancer has been closed early to enable a follow-on trial with FDA regulatory intent.
Viking Therapeutics reports strong results from phase 2 trial of a new anti-obesity drug, VK2735, showing potential to rival other GLP-1 drugs.
A patient in a phase 2 trial has received the first dose of a novel combination of botensilimab and balstilimab plus agenT-979, an allogeneic cell therapy.
The novel drug BMX-001 showed improved survival in certain patients with high-grade glioma and reduced cognitive decline caused by radiation therapy.
Dutch biopharmaceutical company Pharming Group N.V. (PHAR) announced Wednesday its plans to develop leniolisib for additional primary immunodeficiencies or PIDs beyond activated phosphoinositide 3-kinase delta syndrome or APDS.